159 related articles for article (PubMed ID: 9038563)
1. Prospective randomized study of sulindac versus calcium and calciferol for upper gastrointestinal polyps in familial adenomatous polyposis.
Seow-Choen F; Vijayan V; Keng V
Br J Surg; 1996 Dec; 83(12):1763-6. PubMed ID: 9038563
[TBL] [Abstract][Full Text] [Related]
2. Effect of sulindac on small polyps in familial adenomatous polyposis.
Debinski HS; Trojan J; Nugent KP; Spigelman AD; Phillips RK
Lancet; 1995 Apr; 345(8953):855-6. PubMed ID: 7898240
[No Abstract] [Full Text] [Related]
3. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis.
Nugent KP; Farmer KC; Spigelman AD; Williams CB; Phillips RK
Br J Surg; 1993 Dec; 80(12):1618-9. PubMed ID: 8298943
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of eflornithine (CPP-1X)/sulindac combination therapy versus each as monotherapy in patients with familial adenomatous polyposis (FAP): design and rationale of a randomized, double-blind, Phase III trial.
Burke CA; Dekker E; Samadder NJ; Stoffel E; Cohen A
BMC Gastroenterol; 2016 Aug; 16(1):87. PubMed ID: 27480131
[TBL] [Abstract][Full Text] [Related]
5. Sulindac for periampullary polyps in FAP patients.
Richard CS; Berk T; Bapat BV; Haber G; Cohen Z; Gallinger S
Int J Colorectal Dis; 1997; 12(1):14-8. PubMed ID: 9112144
[TBL] [Abstract][Full Text] [Related]
6. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis.
Giardiello FM; Hamilton SR; Krush AJ; Piantadosi S; Hylind LM; Celano P; Booker SV; Robinson CR; Offerhaus GJ
N Engl J Med; 1993 May; 328(18):1313-6. PubMed ID: 8385741
[TBL] [Abstract][Full Text] [Related]
7. Gastroduodenal polyps in familial adenomatous polyposis.
Petrelli NJ; Rodriguez-Bigas M; Weber TK
Surg Endosc; 1996 Nov; 10(11):1118-9. PubMed ID: 8881070
[No Abstract] [Full Text] [Related]
8. Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients.
Sample DC; Samadder NJ; Pappas LM; Boucher KM; Samowitz WS; Berry T; Westover M; Nathan D; Kanth P; Byrne KR; Burt RW; Neklason DW
BMC Gastroenterol; 2018 Jul; 18(1):115. PubMed ID: 30012100
[TBL] [Abstract][Full Text] [Related]
9. Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment.
Spagnesi MT; Tonelli F; Dolara P; Caderni G; Valanzano R; Anastasi A; Bianchini F
Gastroenterology; 1994 Feb; 106(2):362-6. PubMed ID: 8299902
[TBL] [Abstract][Full Text] [Related]
10. Effect of Sulindac and Erlotinib vs Placebo on Duodenal Neoplasia in Familial Adenomatous Polyposis: A Randomized Clinical Trial.
Samadder NJ; Neklason DW; Boucher KM; Byrne KR; Kanth P; Samowitz W; Jones D; Tavtigian SV; Done MW; Berry T; Jasperson K; Pappas L; Smith L; Sample D; Davis R; Topham MK; Lynch P; Strait E; McKinnon W; Burt RW; Kuwada SK
JAMA; 2016 Mar 22-29; 315(12):1266-75. PubMed ID: 27002448
[TBL] [Abstract][Full Text] [Related]
11. Endoscopic management of upper gastrointestinal polyps and periampullary lesions in familial adenomatous polyposis and Gardner's syndrome.
van Stolk R; Sivak MV; Petrini JL; Petras R; Ferguson DR; Jagelman D
Endoscopy; 1987 Nov; 19 Suppl 1():19-22. PubMed ID: 2828015
[TBL] [Abstract][Full Text] [Related]
12. Familial Adenomatous Polyposis; Succesful Use of Sirolimus.
Yuksekkaya H; Yucel A; Gumus M; Esen H; Toy H
Am J Gastroenterol; 2016 Jul; 111(7):1040-1. PubMed ID: 27356835
[No Abstract] [Full Text] [Related]
13. Sulindac causes regression of rectal polyps in familial adenomatous polyposis.
Labayle D; Fischer D; Vielh P; Drouhin F; Pariente A; Bories C; Duhamel O; Trousset M; Attali P
Gastroenterology; 1991 Sep; 101(3):635-9. PubMed ID: 1650315
[TBL] [Abstract][Full Text] [Related]
14. [Sulindac in familial adenomatous polyposis coli--preliminary findings of a prospective study].
Müller A; Hürlimann R; Meyenberger C; Staub P; Kobler E; Ammann R
Schweiz Med Wochenschr; 1994 Apr; 124(15):651-4. PubMed ID: 8191270
[TBL] [Abstract][Full Text] [Related]
15. The role of high-resolution endoscopy and narrow-band imaging in the evaluation of upper GI neoplasia in familial adenomatous polyposis.
Lopez-Ceron M; van den Broek FJ; Mathus-Vliegen EM; Boparai KS; van Eeden S; Fockens P; Dekker E
Gastrointest Endosc; 2013 Apr; 77(4):542-50. PubMed ID: 23352497
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis.
Winde G; Schmid KW; Brandt B; Müller O; Osswald H
Dis Colon Rectum; 1997 Oct; 40(10):1156-68; discussion 1168-9. PubMed ID: 9336110
[TBL] [Abstract][Full Text] [Related]
17. Randomized, placebo-controlled trial of gastric acid-lowering therapy on duodenal polyposis and relative adduct labeling in familial adenomatous polyposis.
Wallace MH; Forbes A; Beveridge IG; Spigelman AD; Hewer A; Venitt S; Phillips RK
Dis Colon Rectum; 2001 Nov; 44(11):1585-9. PubMed ID: 11711728
[TBL] [Abstract][Full Text] [Related]
18. Sulindac therapy of colorectal polyps in familial adenomatous polyposis.
Tonelli F; Valanzano R; Dolara P
Dig Dis; 1994; 12(5):259-64. PubMed ID: 7882547
[TBL] [Abstract][Full Text] [Related]
19. Gastroduodenal polyps in familial adenomatous and juvenile polyposis.
Järvinen HJ; Sipponen P
Endoscopy; 1986 Nov; 18(6):230-4. PubMed ID: 3024956
[TBL] [Abstract][Full Text] [Related]
20. Adenomas of the ampulla of vater in familial adenomatous polyposis: Christian Theodore responds.
Theodore C
Gastroenterology; 2004 Feb; 126(2):628-9. PubMed ID: 14765399
[No Abstract] [Full Text] [Related]
[Next] [New Search]
